Stents under Price Control; Government amends Act

New Delhi: Stents prices will soon have a maximum limit, as the government is moving ahead in its endeavour to bring them under the national list of medicines and hence under price control

Department of Pharmaceuticals has recently come out with the order to amend the Drugs ( Price Control) Order, 2013 in order the include Coronary Stents under the ambit of the order.

These would include

1. Bare Metal Stents (BMS)


2. Drug Eluting Stents (DES) which include metallic DES and Bioresorbable Vascular Scaffold ( BVS/Biodegradable Stents

With the said order passed, the DoP is expected to fix the prices of these stents within the next 60 days with results “NPPA is requested to take further action urgently,” the department has stated in a December 21 letter to Bhupendra Singh, chairman of the pricing regulator.

According to the Ministry of Health and Family Welfare, the move to regulate MRPs of stents had been taken on recommendations from all quarters asking for cardiology devices, including the biodegradable ones, to be put on the list of essential medicines.

Read more : Coronary Stent MRPs’ to be announced within three months: Health Ministry

Read Also: Delhi HC pulls up Government on fixing MRP of coronary stents